We are interested in the effect of TGFβ-induced TSP-1 synthesis and potential interventions to reduce TSP-1 in both normoxic and hypoxic conditions, since TSP-1 levels are found upregulated in PAD patients [13, 107]. The gene discussed is TGFB1; the disease is peripheral arterial disease.